Chemical-structure (Clonidine 01)
Clonidine Patch, Extended Release
Product Images NDC 75907-024
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Clonidine (NDC 75907-024). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Dr. Reddy's Labratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Cross-section (Clonidine 02)
Figure-1 (Clonidine 03 Figure1)
Figure-2-l (Clonidine 04 Figure2 L)
This text provides information about the Clonidine Transdermal System, which delivers 0.1 mg per day for one week. It warns against undergoing an MRI with the patch on to avoid burns. The system contains 3.09 mg of Clonidine along with various inactive ingredients. The product is intended for use as prescribed (Rx Only) and manufactured by Dr. Reddy's Laboratories.*
Figure-2-r (Clonidine 05 Figure2 R)
This text provides information about an adhesive cover that does not contain active medication and should be applied over a patch, if necessary. It also mentions that suggestions for usage can be found in the patient information sheet.*
Figure-3 (Clonidine 06 Figure3)
Figure-4 (Clonidine 07 Figure4)
Figure-5 (Clonidine 08 Figure5)
Figure-6 (Clonidine 09 Figure6)
Principle Display Panel 0.2mg (Clonidine 10 Pdp0.2mg)
This is a description of a Clonidine Transdermal System USP for delivering 0.2 mg per day over the course of one week. It contains specific instructions such as removing the patch before an MRI procedure to avoid burns. The package includes 4 systems and 4 adhesive covers. The transdermal system contains 6.19 mg of clonidine and lists inactive ingredients. It is for transdermal use only, and the usual dosage information can be found in the package insert. The medication should be kept out of reach of children and stored at 20° to 25°C. The product is distributed by Dr. Reddy's Laboratories in Princeton.*
Principle Display Panel 0.1mg (Clonidine 11 Pdp0.1mg)
This is a description of Clonidine Transdermal System USP delivering 0.1 mg/day for one week. Each system contains 3.09 mg of clonidine. It includes instructions such as removing the patch before an MRI, storing at 20-25°C, and keeping out of reach of children. The system consists of 4 systems and 4 adhesive covers with programmed delivery. Inactive ingredients include aluminum, silicon dioxide, and mineral oil. The text specifies it is for transdermal use only with dosage details provided in the package insert.*
Principle Display Panel 0.3mg (Clonidine 12 Pdp0.3mg)
This text provides useful information about Clonidine Transdermal System USP, including the dosage of 0.3 mg/day, instructions for use, and precautions such as avoiding MRI procedures with the patch on to prevent burns. It also lists the inactive ingredients and storage instructions. The product is distributed by Dr. Reddy's Laboratories and contains 4 systems and 4 adhesive covers.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
